川芎嗪联合阿拓莫兰治疗中度酒精性脂肪肝的临床观察

The clinical study of ligustrazine in combination with reduced glutathione for treatment of middle degree alcoholic fatty

观察川芎嗪联合阿拓莫兰治疗中度脂肪肝的疗效。94例中度脂肪肝患者随机分为两组,治疗组52例,使用川芎嗪联合阿拓莫兰;对照组42例,使用甘利欣治疗。治疗前,两组在统计学上具有可比性(P>0.05);治疗后,治疗组较对照组其影像学、GGT、TG改善较明显,有明显差异(P<0.05);而ALT两组均改善,统计学无差异(P>0.05)。川芎嗪联合阿拓莫兰治疗中度脂肪肝是一种有效的方法。

To observe the efficacy of ligustrazine in combination with reduced glutathione for treatment of middle degree alcoholic fatty liver. 94 cases patients were randomly divided into the test group and the control group, the test group (52 caes)was treated with ligustrazine and reduced glutathione, the control group (42 cases) was treated with diammonium glycyrrhizine. Before treatment the two groups were comparable with each other. After treatment, the efficacy of the test group in Imagics,GGT,TG is superior to that of the control group ( P < 0.05), ALT in two groups were better, which were no difference (P > 0.05) . The treatment of ligustrazine in combination with reduced glutathione for middle degree alcoholic fatty liver is effective, but the treatment of diammonium glycyrrhizine is inferior to that.